ASH 2011 Conference Coverage

Cetuximab may be beneficial beyond progression in certain patients with mCRC

Continuing second-line cetuximab beyond progression following first-line chemotherapy and an anti-EGFR monoclonal antibody is beneficial for quadruple wild-type metastatic colorectal cancer.

Study confirms benefit of regorafenib in previously treated metastatic colorectal cancer

Researchers have confirmed that regorafenib is beneficial for the treatment of patients with previously treated metastatic colorectal cancer.

Injury to the big toe leads to an unexpected lymphoma

A seemingly innocuous injury to the foot produces a persistent lesion. Punch biopsy reveals an unusual diagnosis.

Perception of risk from tobacco use is lower among cancer survivors who smoke

A new study identified several factors that inhibit the efforts of cancer survivors who smoke to quit.

Comorbid conditions associated with worse lung cancer survival

Lung cancer patients with comorbid conditions, such as chronic obstructive pulmonary disease or diabetes, had a greater risk of death than lung cancer patients without these conditions.

Benefits found for screening colonoscopies of higher quality

Higher adenoma detection rates may be associated with much lower lifetime colorectal cancer incidence and death without higher overall costs, research indicates.

High-grade cervical lesions declining in young women

A decrease in cervical lesions among young women in the United States has been observed, but the cause for this drop is not proven.

Early relapse of follicular lymphoma may increase risk of death

Early relapse of follicular lymphoma could be carefully considered when making decisions about treatment for these patients.

Study identifies perception gap in incidence, impact of CINV/RINV

There is a perpetual gap between healthcare professionals and patient perceptions of incidence and impact on patients' daily life of CINV/RINV.

Survival in adult patients with low-grade brain tumors has improved

Outcomes for patients with low-grade gliomas have improved significantly in recent years, according to an analysis of clinical data collected from a US cancer registry over the past decade.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs